HIV drug resistance testing is an important tool in managing human immunodeficiency virus (HIV) infection. It helps identify genetic changes in the virus that may reduce the effectiveness of specific antiretroviral medications. Healthcare professionals use these results alongside medical history, viral load measurements, previous treatment experiences, and other clinical information to make informed treatment decisions.
HIV drug resistance testing examines whether genetic changes in the virus affect its response to antiretroviral medicines. HIV can develop mutations as it replicates, and certain mutations may allow the virus to continue multiplying despite the presence of particular medications. Identifying these changes helps healthcare professionals understand which drugs may be less effective.
Two main types of resistance testing are commonly used. Genotypic testing identifies mutations in the viral genetic material associated with resistance. Phenotypic testing measures how well HIV grows in the presence of different antiretroviral medicines compared with a reference virus. Genotypic testing is generally used more frequently because it provides useful information about resistance mutations.
Testing may be considered at different stages of HIV care, depending on the individual's circumstances and treatment history.
At initial diagnosis: Testing can identify drug-resistant HIV transmitted from another person, helping inform the selection of an initial treatment regimen.
During treatment failure: When viral load remains detectable or increases despite treatment, resistance testing can help determine whether drug resistance contributes to the problem.
Before changing treatment: Testing may provide valuable information when a healthcare professional is evaluating alternative medications, particularly for people with a history of treatment failure.
After previous treatment exposure: Earlier resistance results and medication history can help identify mutations that may continue to influence future treatment choices.
Resistance testing is most informative when performed while a person is taking the failing treatment or soon after discontinuation, because resistant viral populations may become less detectable over time without the medicines that selected for them. The appropriate timing depends on the clinical situation.
Resistance test results help healthcare professionals select combinations of antiretroviral medicines that are likely to suppress HIV effectively. The results are not interpreted in isolation. Clinicians also consider viral load, CD4 cell count, previous treatment regimens, medication interactions, potential side effects, other health conditions, and the person's ability to follow the treatment schedule.
When resistance to one or more medicines is identified, the treatment regimen may need to be adjusted. The aim is to construct a combination containing enough fully active medications to achieve and maintain viral suppression. A resistance mutation affecting one drug does not necessarily mean that every medicine in the same class or every available HIV treatment will be ineffective.
Several factors are important when applying test results to treatment planning.
Mutation interpretation: Some mutations affect the activity of particular medications, while others have limited or combined effects. Specialists interpret the overall mutation pattern.
Treatment history: Previous medicines, past viral load results, and earlier resistance tests may reveal resistance that is not detected in the latest sample.
Medication adherence: Missed doses, difficulties obtaining medicines, or problems with absorption can contribute to treatment failure. These factors should be assessed alongside resistance.
Treatment monitoring: Follow-up viral load testing helps determine whether the selected regimen is working. Persistent or increasing viral load may require further evaluation.
Individual circumstances: Possible side effects, drug interactions, other medical conditions, and patient preferences influence the suitability of treatment options.
People receiving HIV treatment should not stop or change their medications independently because of suspected resistance. A healthcare professional can evaluate the findings and recommend appropriate next steps. If resistance testing does not identify relevant mutations, other causes of treatment failure should still be investigated.
HIV drug resistance testing supports individualized treatment planning, but it cannot guarantee a particular outcome. Regular clinical follow-up, consistent access to medication, and ongoing monitoring remain important parts of HIV care. With appropriate evaluation and treatment adjustments, many people living with HIV can achieve and maintain viral suppression.